Cambridge Bioscience is delighted to announce a new strategic distribution partnership with Jena Bioscience, following our recent acquisition of Stratech Scientific. This extends the availability of Jena Bioscience’s innovative molecular biology, protein expression, RNA technology and crystallography solutions for life science, diagnostic R&D and drug discovery researchers across the UK and Ireland.
The partnership will provide scientists with streamlined access to Jena Bioscience’s extensive portfolio of products, including nucleotides and nucleosides, molecular biology reagents, recombinant proteins, RNA synthesis technologies, probes and epigenetics tools, crystallography and Cryo-EM solutions, as well as the company’s renowned LEXSY eukaryotic protein expression system. These advanced technologies support a broad range of applications across molecular biology, cell biology, structural biology, genomics and biotechnology research.
Jena Bioscience is a leading German life science company that develops and manufactures high-quality products for research laboratories, pharmaceutical companies and diagnostic manufacturers worldwide. Operating under DIN EN ISO 9001 and DIN EN ISO 14001 certifications, the company is recognised for helping researchers simplify complex molecular biology workflows through innovative reagents, tools and technologies.
Jena Bioscience offers a comprehensive portfolio spanning nucleic acid chemistry, RNA technologies, molecular biology enzymes and reagents, protein expression systems, diagnostic components, crystallography and Cryo-EM products. Its solutions are trusted by scientists globally for applications ranging from basic research to advanced drug discovery and structural biology studies.
Through this partnership, Cambridge Bioscience will provide local technical support, product expertise and customer service, ensuring researchers across the UK and Ireland can fully leverage Jena Bioscience’s trusted portfolio and innovative technologies to advance their scientific discoveries.
This collaboration further strengthens Cambridge Bioscience’s commitment to supporting the UK and Ireland life science community with high-quality tools and technologies that accelerate research, innovation and discovery.
Learn more about Jena Bioscience’s portfolio or contact our Jena Bioscience specialists.